project id: TCGA-CESC; case submitter id: TCGA-EK-A2PL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.8; age at index: 36; days to birth: -13384; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1972; age at diagnosis: 13384; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 13.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1181; initial weight: 130.0; oct embedded: false; preservation method: Unknown; sample id: 6ee33187-69a7-4328-9521-173cfcde7a1b; sample submitter id: TCGA-EK-A2PL-01A; portion id: 3beb6b77-c7c3-4efb-8234-2caad683d225; portion submitter id: TCGA-EK-A2PL-01A-11; slide id: 2a3e42ce-bffe-4761-90f2-6aa1772b9d73; slide submitter id: TCGA-EK-A2PL-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 7.0; percent stromal cells: 12.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;